The advantage of Python is that you can apply operations to larger datasets with hundreds, even thousands, of data points ...

The company is set to present promising data for its cancer drug Trodelvy at the European Society for Medical Oncology (ESMO) 2025 Congress. The Phase 3 ASCENT-03 study showed significant improvement ...

The Central Board of Secondary Education (CBSE) has issued a fourth reminder to affiliated schools to submit registration data for Class 9 and 11 students for the 2025–26 session by October 16.

ROCKVILLE, Md., Oct. 22, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (I-Mab or the Company), is a global biotechnology platform company committed to accelerating access to innovative medicines for ...

Moderna Inc. (NASDAQ:MRNA) is one of the best high volume stocks to buy according to Wall Street analysts. On October 13, Moderna announced that promising clinical, safety, and translational data from ...

20:03, Tue, Oct 21, 2025 Updated: 20:07, Tue, Oct 21, 2025 Sir Keir Starmer forced Labour MPs to cover up data on migrant crimes to avoid even bigger rows over immigration policies, Robert Jenrick has ...

WATERTOWN, Mass. - Acrivon Therapeutics, Inc. (NASDAQ:ACRV), a clinical-stage biotech company with a market capitalization of $64.17 million and strong cash reserves exceeding its debt obligations, ...

A business.com editor verified this analysis to ensure it meets our standards for accuracy, expertise and integrity. Business.com earns commissions from some listed providers. Editorial Guidelines.

IMNN-001 program is currently advancing its OVATION 3 pivotal Phase 3 trial per plan LAWRENCEVILLE, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc. (Nasdaq: IMNN) , a clinical-stage company in ...

A business.com editor verified this analysis to ensure it meets our standards for accuracy, expertise and integrity. Business.com earns commissions from some listed providers. Editorial Guidelines.

Savara Inc. (NASDAQ:SVRA) is one of the top long-term biotechnology stocks to buy. On October 2, Savara Inc. (NASDAQ:SVRA) announced that its partner, TrilliumBiO, will present data on the development ...